Cyclooxygenase-2 inhibitors and cardiovascular thromboembolic events.
William B
WB
White
D000818:Animals; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000378:metabolism*; D003328:Coronary Thrombosis / Q000139:chemically induced* / Q000378:metabolism*; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes / Q000009:adverse effects* / Q000378:metabolism*; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases / Q000009:adverse effects* / Q000378:metabolism*
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases